Clinical Trial Update: Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia [Phase 3]

View source ↗

Summary

Phase 3 study in Ethiopia evaluating antimicrobial adjuvants to balance skin microbiota for improved outcomes in complicated cutaneous leishmaniasis. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Leishmaniasis, Cutaneous | Phase 3 | Status: NOT_YET_RECRUITING